Order results by:
| Issue | Title | |
| Vol 4, No 1 (2012) | Generalized epilepsies: current conceptions and therapeutic approaches | Abstract similar documents |
| L R Zenkov | ||
| "... , dosage form, side effects, and cost. Among broad-spectrum agents (valproate (VPA), levetiracetam ..." | ||
| Vol 4, No 1S (2012): Special issue "Epilepsy" | New antiepileptic drugs, cost-efficacy analysis | Abstract similar documents |
| P. N. Vlasov, N. V. Orekhova, T. I. Konovalova | ||
| "... and cost-effectiveness of its therapy with the new antiepileptic drugs (AED): levetiracetam, lamotrigine ..." | ||
| Vol 4, No 1S (2012): Special issue "Epilepsy" | Long-term levetiracetam monotherapy for partial epilepsy in adults | Abstract similar documents |
| P. N. Vlasov, V. A. Karlov, E. G. Komelkova, Z. S. Shakhabasova | ||
| "... The paper analyzes the efficiency of 3-year monotherapy with levetiracetam (LTC) (keppra) in 143 ..." | ||
| Vol 9, No 3 (2017) | Clinical results of and prospects for the use of controlled-release antiepileptic drugs: a new once-daily levetiracetam formulation | Abstract similar documents |
| P. N. Vlasov | ||
| "... . The emergence of a new sustained-release levetiracetam formulation in neurologists' practice greatly enhances ..." | ||
| Vol 6, No 1S (2014): Special issue "Epilepsy" | Intravenous Antiepileptic Drugs in Russia | Abstract similar documents |
| P. N. Vlasov | ||
| "... (Vimpat), and levetiracetam (Keppra) – into the Russian market has significantly broadened ..." | ||
| No 1S (2016): | Status epilepticus: Analysis of refractory cases | Abstract similar documents |
| B. P. Gladov, O. A. Podgornaya, P. N. Vlasov | ||
| "... antiepileptic drugs (AEDs), such as diazepam (DZP); valproic acid (VPA); levetiracetam; and lacosamide ..." | ||
| Vol 7, No 1S (2015): Special issue "Epilepsy" | Efficacy of generic levetiracetam (epiterra) in monotherapy for epilepsy in adult patients: preliminary results | Abstract similar documents |
| V. A. Karlov, P. N. Vlasov, I. A. Zhidkova | ||
| "... Objective: to evaluate the efficacy and tolerability of levetiracetam (LEV) (epiterra, TEVA ..." | ||
| Vol 10, No 1S (2018): СПЕЦВЫПУСК: ЭПИЛЕПСИЯ | An open-label prospective clinical study of the efficacy and tolerability of brand-name and generic levetiracetam in the monotherapy of focal epilepsy in adults | Abstract similar documents |
| V. A. Karlov, P. N. Vlasov, I. A. Zhidkova | ||
| "... with levetiracetam (LEV), a brand-name drug (bLEV; Keppra, UCB Pharma, Belgium) and its generic (gLEV; Epiterra ..." | ||
| 1 - 8 of 8 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
